ARLINGTON, Va., Nov. 16, 2018 /PRNewswire/ -- John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Forceand advisor to SOCMA's PharmaChem Sector will participate in a panel discussion about Manufacturing and Supply Challenges at a U.S. Food & Drug Administration event sponsored by Duke Margolis Center for Health Policy. The summit on Identifying the
"I am honored to serve on this distinguished panel. With so many factors impacting drug shortages, as well as challenges related to economic drivers and market competition, this event comes at a critical time as active pharmaceutical ingredient manufacturers refine their business plans and strategy for 2019 and beyond," said DiLoreto.
Key discussion questions for the panel include:
Other key topics throughout the day will focus on federal efforts to prevent drug shortages, the economics of drug shortages, the health impacts and economic consequences of drug shortages, drug purchasing and demand challenges, and strategies and next steps to reduce adverse clinical and economic consequences and safeguard public health.
This event is open to the public.
About BPTFThe Bulk Pharmaceuticals Task Force (BPTF), an affiliate of SOCMA, is an industry trade organization for manufacturers of active pharmaceutical ingredients (APIs), their intermediates and excipients.
View original content:http://www.prnewswire.com/news-releases/john-diloreto-to-discuss-manufacturing--supply-chain-challenges-at-fda-summit-300752219.html
SOURCE Bulk Pharmaceuticals Task Force
Subscribe to our Free Newsletters!